Omidria (Ketorolac, Phenylephrine)

Ketorolac, the active ingredient in Omidria, is a non‑steroidal anti‑inflammatory drug presented as a sterile ophthalmic solution for intra‑operative ocular use. It helps control postoperative inflammation and pain following cataract surgery. GNH USA supplies Omidria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

GNH USA supplies Omidria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

Omidria combines ketorolac and phenylephrine to address ocular inflammation and pupil dilation pathways during eye surgery. It is indicated for: - Cataract surgery: reduces the need for separate NSA‑non‑steroidal anti‑inflammatory drugs and pain management post‑operatively. - Intra‑ocular procedures : provides both anti‑inflammatory and mydriatic effects to facilitate surgical maneuver m ​  . - Small small   . -  . -  . -  t